Health Care·NYSE·All covered stocks

Cardinal Health Inc. (NYSE: CAH) Stock News & Analysis

Cardinal Health Inc. (NYSE: CAH) is a healthcare company, listed on the NYSE. Alpha Stocks Insight has published 3 articles on CAH since April 30, 2026, most recently "Cardinal Health (NYSE: CAH) Q4 FY2026: Adjusted EPS of $2.91 Beats by 19%, FY2027 Guidance Set at $12.40-$12.60" on Tuesday, August 11, 2026. Coverage to date spans Earnings Report, tracking CAH's earnings, analyst activity, and material corporate events. New coverage is added each trading day.

Price

$240.00

Today

-0.20%

Mkt Cap

$55.8B

P/E

32.7x

52W High

$258.30

52W Low

$145.87

Data via Finnhub · refreshes hourly · not financial advice

CAH Coverage -- 3 Articles

Earnings Report·Tuesday, August 11, 2026

Cardinal Health (NYSE: CAH) Q4 FY2026: Adjusted EPS of $2.91 Beats by 19%, FY2027 Guidance Set at $12.40-$12.60

Cardinal Health beat Q4 adjusted EPS by 19.1% and issued FY2027 guidance of $12.40-$12.60, projecting 13%-15% non-GAAP EPS growth above its long-term target.

4 min readRead article

Important Legal Disclaimer

This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.

Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.

Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.